Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Developing and adopting safe and effective digital biomarkers to improve patient outcomes

Open access
Coravos, Andrea, Khozin, Sean, Mandl, Kenneth D. · 2019 · npj Digital Medicine

Abstract

Biomarkers are physiologic, pathologic, or anatomic characteristics that are objectively measured and evaluated as an indicator of normal biologic processes, pathologic processes, or biological responses to therapeutic interventions. Recent advances in the development of mobile digitally connected technologies have led to the emergence of a new class of biomarkers measured across multiple layers of hardware and software. Quantified in ones and zeros, these “digital” biomarkers can support continuous measurements outside the physical confines of the clinical environment. The modular software–hardware combination of these products has created new opportunities for patient care and biomedical research, enabling remote monitoring and decentralized clinical trial designs. However, a systematic approach to assessing the quality and utility of digital biomarkers to ensure an appropriate balance between their safety and effectiveness is needed. This paper outlines key considerations for the development and evaluation of digital biomarkers, examining their role in clinical research and routine patient care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41746-019-0090-4

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Digital biomarker products. Five products, all detecting a similar digital endpoint, are constructed with differing, modular approaches. In the first column are five products to detect atrial fibrillation: AliveCor, CardioGram, Apple Watch plus ECG App, Fitbit, and Xiaomi. Across the top, are major software modules comprising the product, from the operating system on the left to the user interface on the right. Some modules are created by the product manufacturer and others by a third party. If the listed organization manufacturers the component, the module is represented in green. If instead it is created by a different party, the color is gray. These differently composed products require different strategies for verification, validation, and likely also regulatory clearance. Figures are reused with permission from the copyright owners, and the Apple watch image is Courtesy of Apple Inc
Fig. 1 Digital biomarker products. Five products, all detecting a similar digital endpoint, are constructed with differing, modular approaches. In the first column are five products to detect atrial fibrillation: AliveCor, CardioGram, Apple Watch plus ECG App, Fitbit, and Xiaomi. Across the top, are major software modules comprising the product, from the operating system on the left to the user interface on the right. Some modules are created by the product manufacturer and others by a third party. If the listed organization manufacturers the component, the module is represented in green. If instead it is created by a different party, the color is gray. These differently composed products require different strategies for verification, validation, and likely also regulatory clearance. Figures are reused with permission from the copyright owners, and the Apple watch image is Courtesy of Apple IncCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 361

Metadata

Authors
Coravos, A., Khozin, S., & Mandl, K. D.
Affiliations
  • Boston Children's Hospital (US)
  • United States Food and Drug Administration (US)
Corresponding author
Mandl, Kenneth D.
Venue
npj Digital Medicine
Published
2019-03-11
Volume
2
Issue
1
ISSN
2398-6352 (ISSN-L)
OpenAlex
W2921623465
Cited by
361
References
20
Citations by year
2026: 68 · 2025: 50 · 2024: 42 · 2023: 44 · 2022: 42 · 2021: 47 · 2020: 56 · 2019: 12
FWCI
53.48
Type
journal article
Language
en
Open access
Licence
Locations
  • npj Digital Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • U.S. Department of Health & Human Services | National Institutes of Health (R01GM104303)
  • Boston Children's Hospital, PrecisionLink Initiative
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Surgery › Healthcare Technology and Patient Monitoring
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
Keywords
digital biomarkers, mobile health technology, remote patient monitoring, decentralized clinical trials, biomarker validation, safety and effectiveness, clinical research, patient care, wearable devices

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Developing and adopting safe and effective digital biomarkers to improve patient outcomes. https://app.cochat.ai/papers/10.1038/s41746-019-0090-4
The paper
Coravos, A., Khozin, S., & Mandl, K. D. (2019). Developing and adopting safe and effective digital biomarkers to improve patient outcomes. npj Digital Medicine. https://doi.org/10.1038/s41746-019-0090-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.